Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
European stocks set for muted open after European Central Bank cut
Tags Europe Markets Voting Ibex Ltd
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Small Business Playbook Personal finance Weight loss diets
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Mad Money Stock markets Datadog Inc
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Amgen Inc stocks Pharmaceuticals
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Teladoc Health Inc WW International Inc Hims & Hers Health Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health & Science Healthy Returns Health care industry
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Business AstraZeneca PLC Health
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Business Technology Novo Nordisk A/S
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Companies Health & Science Breaking news
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Eli Lilly and Co Biotech and Pharmaceuticals Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Novo Nordisk A/S Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health & Science Healthy Returns Health care industry
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Structure Therapeutics Inc Companies Health & Science
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Business News Companies Health & Science
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Pharmaceuticals Novo Nordisk A/S Earnings
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Health & Science Breaking news Companies
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Politics Novo Nordisk A/S Policy
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Social issues Health care industry Biotechnology
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Molson Coors Beverage Co Health care industry Diageo PLC
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Health care industry Biotechnology Pharmaceuticals
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Business News US: News Pharmaceuticals
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Europe News Food and Beverage Health care industry
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Health & Science Healthy Returns Health care industry
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Business News Pharmaceuticals Altimmune Inc
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Pharmaceuticals US: News Business News
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Eli Lilly and Co Business Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.